|
Mar 15
|
ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript
|
|
Mar 14
|
Q4 2023 ADC Therapeutics SA Earnings Call
|
|
Mar 13
|
ADC Therapeutics SA (ADCT) Reports Mixed 2023 Financial Results Amid Strategic Reset
|
|
Mar 13
|
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 13
|
ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
|
|
Mar 11
|
Adobe (ADBE) to Report Q1 Earnings: What's in the Offing?
|
|
Mar 6
|
Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates
|
|
Mar 6
|
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
|
|
Mar 6
|
ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024
|
|
Mar 5
|
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting
|
|
Feb 27
|
ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
|
|
Jan 19
|
ADC Therapeutics (ADCT) Rises 43% in a Month: Here's Why
|
|
Jan 19
|
Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?
|
|
Jan 4
|
ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards
|
|
Jan 4
|
ADC Therapeutics Provides Business Updates
|
|
Nov 15
|
Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur and ADC Pioneer, as Chairman of its Board of Directors
|
|
Nov 8
|
ADC Therapeutics SA (NYSE:ADCT) Q3 2023 Earnings Call Transcript
|
|
Nov 8
|
Q3 2023 ADC Therapeutics SA Earnings Call
|
|
Nov 7
|
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue Estimates
|
|
Nov 7
|
ADC Therapeutics Receives NYSE Notice of Non-Compliance With Continued Listing Standards
|